Improvement in measures of psychological distress amongst amphetamine misusers treated with brief cognitive-behavioural therapy (CBT)

Feeney, GFX, Connor, JP, Young, RM, Tucker, J and McPherson, A (2006) Improvement in measures of psychological distress amongst amphetamine misusers treated with brief cognitive-behavioural therapy (CBT). Addictive Behaviors, 31 10: 1833-1843. doi:10.1016/j.addbeh.2005.12.026


Author Feeney, GFX
Connor, JP
Young, RM
Tucker, J
McPherson, A
Title Improvement in measures of psychological distress amongst amphetamine misusers treated with brief cognitive-behavioural therapy (CBT)
Journal name Addictive Behaviors   Check publisher's open access policy
ISSN 0306-4603
Publication date 2006
Sub-type Article (original research)
DOI 10.1016/j.addbeh.2005.12.026
Volume 31
Issue 10
Start page 1833
End page 1843
Total pages 11
Editor P. M. Miller
Place of publication UK
Publisher Pergamon
Collection year 2006
Language eng
Subject C1
321021 Psychiatry
730205 Substance abuse
Abstract This trial of cognitive-behavioural therapy (CBT) based amphetamine abstinence program (n = 507) focused on refusal self-efficacy, improved coping, improved problem solving and planning for relapse prevention. Measures included the Severity of Dependence Scale (SDS), the General Health Questionnaire-28 (GHQ-28) and Amphetamine Refusal Self-Efficacy. Psychiatric case identification (caseness) across the four GHQ-28 sub-scales was compared with Australian normative data. Almost 90% were amphetamine-dependent (SDS 8.15 +/- 3.17). Pretreatment, all GHQ-28 sub-scale measures were below reported Australian population values. Caseness was substantially higher than Australian normative values {Somatic Symptoms (52.3%), Anxiety (68%), Social Dysfunction (46.5%) and Depression (33.7%). One hundred and sixty-eight subjects (33%) completed and reported program abstinence. Program completers reported improvement across all GHQ-28 sub-scales Somatic Symptoms (p < 0.001), Anxiety (p < 0.001), Social Dysfunction (p < 0.001) and Depression (p < 0.001)}. They also reported improvement in amphetamine refusal self-efficacy (p < 0.001). Improvement remained significant following intention-to-treat analyses, imputing baseline data for subjects that withdrew from the program. The GHQ-28 sub-scales, Amphetamine Refusal Self-Efficacy Questionnaire and the SDS successfully predicted treatment compliance through a discriminant analysis function (p <.001). (c) 2005 Elsevier Ltd. All rights reserved.
Keyword Psychology, Clinical
Substance Abuse
Amphetamines
Cognitive-behavioural Therapy
Health Perception
Drug-users
Australia
Validity
Dependence
Cocaine
Sydney
Scale
Q-Index Code C1

Document type: Journal Article
Sub-type: Article (original research)
Collections: Excellence in Research Australia (ERA) - Collection
2007 Higher Education Research Data Collection
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 6 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 8 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 15 Aug 2007, 10:37:39 EST